🇺🇸 0.45%NaCl in United States

17 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 17

Most-reported reactions

1. Drug Level Below Therapeutic — 4 reports (23.53%)
2. Therapeutic Response Decreased — 4 reports (23.53%)
3. Dyspnoea — 2 reports (11.76%)
4. Accidental Exposure — 1 report (5.88%)
5. Anti Factor Xa Activity Decreased — 1 report (5.88%)
6. Aspergillus Infection — 1 report (5.88%)
7. Blister — 1 report (5.88%)
8. Blood Creatinine Increased — 1 report (5.88%)
9. Blood Potassium Increased — 1 report (5.88%)
10. Botulism — 1 report (5.88%)

Source database →

Frequently asked questions

Is 0.45%NaCl approved in United States?

0.45%NaCl does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for 0.45%NaCl in United States?

Hamilton Health Sciences Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.